Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test

Diabetes Care

Volumn 41, Issue 8, 2018, Pages 1707-1716

  Arslanian, Silva A ^a   Kahn, Steven E ^a   Buchanan, Thomas A ^a   Edelstein, Sharon L ^a   Ehrmann, David A ^a   Nadeau, Kristen J ^a   Palmer, Jerry P ^a   Utzschneider, Kristina M ^a  

^a Westat   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; METFORMIN;

ADOLESCENT; ADULT; CHILD; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FASTING; FEMALE; HUMAN; HYPERGLYCEMIC CLAMP TECHNIQUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INSULINOGENIC INDEX; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PARALLEL DESIGN; SCHOOL CHILD; AGED; ANALYSIS; BLOOD; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 85053928817     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc18-0243     Document Type: Conference Paper

References (36)

1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of over weight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377:13-27
2. Mayer-Davis EJ, Lawrence JM, Dabelea D, et al.; SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 2017; 376:1419-1429
3. Hannon TS, Arslanian SA. The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Ann N Y Acad Sci 2015; 1353: 113-137
4. The RISE Consortium. Restoring Insulin Secretion (RISE): design of studies of β-cell preservationin prediabetes and early type 2 diabetes across the life span. Diabetes Care 2014; 37:780-788
5. The RISE Consortium. Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp. Diabetes Care 2018; 41:1696-1706
6. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesityworldwide: international survey. BMJ 2000; 320:1240-1243
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-1197
8. Peterson CM, Su H, Thomas DM, et al. Triponderal mass index vs body mass index in estimating body fat during adolescence. JAMA Pediatr 2017; 171:629-636
9. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42:1663-1672
10. George L, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab 2011; 96:2136-2145
11. Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ. How to measure insulin clearance. Diabetes Metab Rev 1994; 10:119-150
12. Seltzer HS, Allen EW, Herron AL Jr, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 1967; 46:323-335
13. Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994; 11:286-292
14. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group. β-Cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002; 51:2170-2178
15. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R. β-Cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005; 54:1735-1743
16. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: insulin resistance, β-cellfailure, or both? Diabetes Care 2005; 28:638-644
17. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008; 31(Suppl. 2):S262-S268
18. Chen ME, Chandramouli AG, Considine RV, Hannon TS, Mather KJ. Comparison of β-cell function between overweight/obese adults and adolescents across the spectrum of glycemia. Diabetes Care 2018; 41:318-325
19. Arslanian S, Kim JY, Nasr A, et al. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: who is worse off? Pediatr Diabetes 2018; 19:205-211
20. Nuutila P, Knuuti MJ, Mäki M, et al. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 1995; 44:31-36
21. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 1995; 80:172-178
22. Goran MI, Bergman RN, Cruz ML, Watanabe R. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 2002; 25:2184-2190
23. Kolterman OG, Reaven GM, Olefsky JM. Relationship between in vivo insulin resistance and decreased insulin receptors in obese man. J Clin Endocrinol Metab 1979; 48:487-494
24. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991; 72:277-282
25. Arslanian SA, Kalhan SC. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes 1994; 43:908-914
26. Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999; 48:2039-2044
27. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008; 118:2992-3002
28. Soman VR, Koivisto VA, Deibert D, Felig P, DeFronzo RA. Increased insulin sensitivity and insulin binding to monocytes after physical training. N Engl J Med 1979; 301:1200-1204
29. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 1982; 54:131-138
30. Valdes CT, Elkind-Hirsch KE. Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab 1991; 72:642-646
31. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation ofintra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002; 51:1005-1015
32. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013; 36:1749-1757
33. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012; 366:2247-2256
34. Kahn SE, Haffner SM, Heise MA, et al.; ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355:2427-2443
35. Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effects of lifestyle intervention and metformin. Diabetes 2005; 54: 2404-2414
36. Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: amulti centrer and omisedparallel-group trial. Lancet 2008; 371:1753-1760